{{Rsnum
|rsid=1004446
|Gene=IGF2
|Chromosome=11
|position=2148913
|Orientation=plus
|GMAF=0.3462
|Gene_s=IGF2,INS-IGF2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.1 | 46.0 | 15.9
| HCB | 50.4 | 39.4 | 10.2
| JPT | 55.8 | 38.9 | 5.3
| YRI | 31.3 | 49.0 | 19.7
| ASW | 26.3 | 54.4 | 19.3
| CHB | 50.4 | 39.4 | 10.2
| CHD | 56.0 | 41.3 | 2.8
| GIH | 55.4 | 38.6 | 5.9
| LWK | 50.0 | 37.3 | 12.7
| MEX | 46.6 | 51.7 | 1.7
| MKK | 64.1 | 28.8 | 7.1
| TSI | 42.2 | 49.0 | 8.8
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=17632545
|Trait=Type 1 diabetes
|Title=A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene
|RiskAllele=C
|Pval=4.0000000000000002E-9
|OR=1.61
|ORtxt=[1.37-1.89]
}}

{{PMID Auto GWAS
|PMID=21829393
|Trait=None
|Title=Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.
|RiskAllele=G
|Pval=3E-23
|OR=1.4000
|ORtxt=[NR]
|OA=1
}}

{{PMID Auto
|PMID=17980034
|Title=Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'.
|OA=1
}}

{{PMID Auto
|PMID=18647951
|Title=A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3.
|OA=1
}}

{{PMID Auto
|PMID=18840781
|Title=Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=19136655
|Title=Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium.
|OA=1
}}

{{PMID Auto
|PMID=19732865
|Title=A generalized family-based association test for dichotomous traits.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=19956106
|Title=Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.
|OA=1
}}

{{PMID Auto
|PMID=21078522
|Title=Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1004446
|overall_frequency_n=42
|overall_frequency_d=124
|overall_frequency=0.33871
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=40
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=24824313
|Title=Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival
}}

{{PMID Auto
|PMID=25037061
|Title=Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival
}}

{{PMID Auto
|PMID=25117571
|Title=Circulating IGF1 and IGF2 and SNP genotypes in pregnant and non-pregnant women and men
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}